Enabling clinicians to achieve superior outcomes
Sensitivity and specificity in Molecular Diagnostics has made RT-PCR a preferred choice with healthcare professionals
Allure for RT-PCR in Molecular diagnostics lies in its sensitivity and specificity and this can be applied to four areas of clinical testing: rapid identification, screening, classification, and monitoring. Each category has different clinical, operational, and economic benefits that maximize patient care. The use of RT-PCR has increased substantially and has paved the way for superior healthcare in clinical microbiology / infectious diseases, oncology and gene therapy. RT-PCR is becoming the gold standard in diagnostics test for delivering accurate, sensitive, and faster turnaround for a large range of diseases.
Diagnostics
Confirmation and differentiation
Monitoring
Disease response during treatment
Screening
Detect the presence of disease in advance / early stage
Treatment Decision
Treatment duration and prognosis
Test of Cure
End of treatment and follow up
Rivaara Labs uses advanced automated technologies and its presence across cities makes it possible for almost every clinician to access sophisticated molecular diagnostic tests. Rivaara’s strong quality orientation ensures a high degree of standardisation while working with clinical samples. Rivaara, through extensive internal studies has also optimised assays, and kits before systemising the test across laboratories. This ensures desired sensitivity precision, accuracy and reproducibility.
